Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$3.5M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 5 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 9 most recent Form 4 transactions.
| GGIFT |
| 2,441 |
| — |
| — |
| -9.4% |
| Open the original filing on SEC.gov |
| Jun 1 | NBIX | Neurocrine Biosciences INC | MEXER◷◆ | 11,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 1 | NBIX | Neurocrine Biosciences INC | SSELL◷ | 11,000 | $160.25 | $1.8M | -29.8% | Open the original filing on SEC.gov |
| Jun 1 | NBIX | Neurocrine Biosciences INC | MEXER◷ | 11,000 | $84.74 | $932.1K | +42.6% | Open the original filing on SEC.gov |
| May 27 | NBIX | Neurocrine Biosciences INC | MEXER◷◆ | 11,000 | — | — | — | Open the original filing on SEC.gov |
| May 27 | NBIX | Neurocrine Biosciences INC | SSELL◷ | 11,000 | $155.53 | $1.7M | -29.8% | Open the original filing on SEC.gov |
| May 27 | NBIX | Neurocrine Biosciences INC | MEXER◷ | 11,000 | $84.74 | $932.1K | +42.6% | Open the original filing on SEC.gov |